Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-25-057811

Director acquired 1,045 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Grissinger Michael Director 2025-06-05 Grant or award +1,045 2,889 D
Derivatives
Grissinger Michael Director 2025-06-05 Grant or award · Stock Options (Right to Buy) +4,185 4,185 D
Loading xslF345X05/tm2517366-3_4seq1.xml…